SCHEMBL14445375

SCHEMBL14445375

Oc1ccc(Cn2nnc3ncc(Br)nc32)cc1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MET P08581 19/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5368225 0.86 MET (0.70) MET
SCHEMBL14445376 0.83 MET (0.65) MET
SCHEMBL16042878 0.76 GRM2 (0.52) MET
SCHEMBL12689580 0.76 MET (0.66) MET
SCHEMBL1163320 0.76 MET (0.76) MET
SCHEMBL18418027 0.76 MET (0.67) MET
SCHEMBL16587101 0.76 MET (0.48) MET
SCHEMBL22109388 0.75 MET (0.48) MET
SCHEMBL2569616 0.74 MET (0.66) MET
SCHEMBL12482456 0.73 MET (0.66) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250417-B2 Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitors SUGEN INC. (US) 2007-07-31 US disclosed
US-7250417-B2 Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitors SUGEN INC. (US) 2007-07-31 US disclosed